Biosimilar Medications Could Create Billions in Health Care Savings

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade.

Source: RAND - November 3, 2014 Category: Health Management Authors: RAND Corporation Source Type: news